🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521886-28-00
Withdrawn Phase I

First-in-Human trial of DS9051b in participants with advanced solid tumors

2025-521886-28-00 · tracked via the Priya Life Science EU tracker
Sponsor
Daiichi Sankyo Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
03/12/2025
Enrollment target
15
Sites
France

Condition studied

Advanced or Metastatic Adrenocortical Carcinoma (ACC), Metastatic Castration-resistant Prostate Cancer (CRPC)

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521886-28-00 on CTIS ↗ ← All trials in the EU